New nomenclature for chromatin-modifying enzymes.

969 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The world of protein acetylation. (2016, background): “the enzymes have been renamed lysine (K) acetyltransferases (KATs) [15].”
Cancer epigenetics reaches mainstream oncology (2011, background): “The enzymes that add and remove such modifications are, respectively, histone acetyltransferases (HATs) and deacetylases (HDACs and sirtuins), methyltransferases (HMTs) and demethylases (HDMs), kinases and phosphatases, ubiquitin ligases and deubiquitinases, SUMO ligases and proteases, and so o”
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL) (2015, background): “Suppressor of variegation 3-9 homologue 2 (SUV39H2), also known as KMT1B, is a SET-domain–containing histone methyltransferase that is expressed only in testis among normal tissues [17].”
Lysine acetylation: codified crosstalk with other posttranslational modifications (2008, background): “There are three major groups of HATs: Gcn5-related N-acetyltransferases (GNATs), E1A-associated protein of 300 kDa (p300)/ CREB-binding protein (CBP), and MYST proteins (Allis et al., 2007; Lee and Workman, 2007).”
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. (2008, background): “The identification of the amine oxidase LSD1 (KDM1 according to the newly suggested nomenclature) (Allis et al. 2007) as a histone demethylase changed this perception (Shi et al.”